Report
EUR 86.16 For Business Accounts Only

37 Stocks for March 2018 (Abbreviated)

This is an update to our logn/short model portfolio strategies that rebalance monthly. This report contains three of our favorite long ideas, and our three favorite short sale ideas. 

Underlyings
Baker Hughes Company Class A

Baker Hughes is an energy technology company. The company's segments are: Oilfield Services, which provides products and services for onshore and offshore operations ranging from drilling, evaluation, completion, production, and intervention; Oilfield Equipment, which provides products and services for the subsea, offshore surface and onshore operating environments; Turbomachinery and Processing Solutions, which provides equipment and related services for mechanical-drive, compression and power-generation applications; and Digital Solutions, which includes condition monitoring, industrial controls, non-destructive technologies, measurement, sensing, and pipeline solutions.

CBRE GROUP INC

CBRE Group is a holding company. Through its subsidiaries, the company is a commercial real estate services and investment firm. The company's segments include: Advisory Services, which provides a range of services globally, including property leasing and capital markets; Global Workplace Solutions, which provides a suite of integrated, contractually-based outsourcing services globally for occupiers of real estate; and Real Estate Investments, which is comprised of investment management services provided globally, development services in the United States and United Kingdom and a service designed to help property occupiers and owners meet the demand for flexible office space solutions on a global basis.

MKS Instruments Inc.

MKS Instruments is a provider of instruments, subsystems and process control solutions. The company has two segments: Vacuum & Analysis, which provides instruments, components, subsystems and software which are derived from its knowledge in pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, residual gas analysis, leak detection, control and information technology, ozone generation and delivery, radio frequency and data communication power, reactive gas generation and vacuum technology; and Light & Motion, which provides instruments, components and subsystems which are derived from its knowledge in lasers, photonics and optics.

Molina Healthcare Inc.

Molina Healthcare is a holding company. Through its subsidiaries, the company provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The company has two segments: Health Plans and Other. The company's health plans are operated by its respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization. The company's business includes: Medicaid, which provides health care and long-term care services and support to low-income Americans; and Medicare, which provides eligible persons age 65 and over and some disabled persons with a variety of hospital, medical insurance, and prescription drug benefits.

Puma Biotechnology Inc.

Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to improve cancer care. The company in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the human epidermal growth factor receptors, HER1, HER2 and HER4. The company is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers.

Zoetis Inc. Class A

Zoetis is a holding company. Through its subsidiaries, the company is engaged in the discovery, development, manufacture and commercialization of animal health medicines, vaccines, and diagnostic products with a focus on both livestock and companion animals. The company operates in two segments: the United States and International. The company's main product categories are vaccines, anti-infectives, parasiticides, other pharmaceutical products, dermatology products, medicated feed additives, and animal health diagnostics. The company's other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services including biodevices, genetic tests and precision livestock farming.

Provider
Ascendere Associates LLC
Ascendere Associates LLC

J. Stephen Castellano founded Ascendere Associates LLC to provide innovative equity research and investment advisory services that blends fundamental and quantitative approaches.

In general, our approach is quite simple -- we believe that return on invested capital and long-term earnings growth are key to stock valuation.  More specifically, we use powerful and unique financial models that combine publicly available data, consensus estimates and our own inputs to generate consistent and actionable stock recommendations. 

Among the services that Ascendere provides are: 1) detailed custom equity research analysis; 2) valuation scenario analysis studies; 3) long/short model portfolio strategies; 4) long and short idea generation; 5) portfolio feedback; 6) detailed fundamental financial modeling services; and 7) additional analytical consulting services. Recent financial modeling consulting clients have included several notable startups as well as BCG Platinion, the risk management division of Boston Consulting Group.  

Mr. Castellano has over 20 years of experience in equity research and related consulting work.  At PaineWebber, Warburg Dillon Read and Credit Lyonnais Securities he developed fundamental equity valuation models and conducted in-depth research on the steel and telecom services industries.  At Boston Private Value Investors, he developed quantitative models for stock idea generation and also provided general fundamental equity research coverage. Steve received a MBA from the F. W. Olin School of Business at Babson College (2005) and a BA from Oberlin College (1993). 

Mr. Castellano's career history is highlighted below:

  • Ascendere Associates, LLC (2009-Present)
  • Boston Private Value Investors , Equity Research, Equity Research Analyst (2005-2009)
  • Pyramid Research, Contract Consultant, Telecom Services (2002-2003)
  • Credit Lyonnais Securities (USA), Equity Research, Telecom Services, Vice President (2000-2001)
  • Warburg Dillon Read, Equity Research, Telecom Services, Research Associate (1999-2000)
  • PaineWebber, Equity Research, Steel and Nonferrous Metals, Research Associate, Editor (1995-1999)

Other Reports on these Companies
Other Reports from Ascendere Associates LLC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch